(Q34800158)

4 August 2017

1 reference

title

The new cholesterol guidelines. Applying them in clinical practice (English)

1 reference

4 August 2017

Brian L Pearlman

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

4 August 2017

published in

Postgraduate Medicine

1 reference

4 August 2017

volume

112

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

13-6, 19-22, 25-6 passim

1 reference

Cholesterol and mortality. 30 years of follow-up from the Framingham study

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Diabetes and all-cause and coronary heart disease mortality among US male physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Blood levels of long-chain n-3 fatty acids and the risk of sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Hypertriglyceridemia as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Do triglycerides provide meaningful information about heart disease risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Atherogenicity of triglyceride-rich lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2002.08.1269

21 January 2018

Identifiers

DOI

10.3810/PGM.2002.08.1269

1 reference

4 August 2017

1 reference